Solesence Q1 revenue falls 11%, posts net loss

Solesence

12/05/2026 13:10

Overview

US health care solutions firm's Q1 revenue declined yr/yr, net loss reported

Gross margin rose to 26% from 23% on operational excellence efforts

Investments in restructuring and training improved efficiency but pressured profitability

Outlook

Company expects improved operational and financial results as the year progresses

Company anticipates benefits from efficiency gains and reduced labor costs

Solésence continues to advance its Transform and Transcend strategic initiative

Result Drivers

OPERATIONAL EXCELLENCE - Co said disciplined execution of its operational excellence initiative improved gross margin

RESTRUCTURING AND TRAINING - Investments in operational infrastructure, including employee training and organizational restructuring, improved efficiency and reduced labor costs but pressured profitability, per CFO Laura Riffner

NEW TECHNOLOGY COMMERCIALIZATION - Commercialization of new platform technologies expanded OTC claims

Company press release: ID:nGNX5VJXYZ

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
$13 mln
Q1 EPS
-$0.01
Q1 Net Income
-$766,000
Q1 Adjusted EBITDA
-$107,000
Q1 Gross Profit
$3.34 mln
Q1 Pretax Profit
-$766,000


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)